Search
for
Sort by
Research 811–840 of 1000+
- Clinical and molecular genetic studies in hereditary hair loss
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Androgenetic alopecia: An update
- Recurrent Toxic Hepatitis in a Caucasian Girl Related to the Use of Shou-Wu-Pian, a Chinese Herbal Preparation
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Novel <i>KRT83</i> and <i>KRT86</i> mutations associated with monilethrix
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- First symposium on natural gene therapy of the skin
- Mimicking fat grafting of fibrotic scars using 3D‐organotypic skin cultures
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Effects of photobiomodulation on human hair dermal papilla cells with various light modes and light parameters
- Pitfalls of overzealous iconodiagnosis of the <i>Girl with a Pearl Earring</i>
- 5α-Reductase underscores the development of pectoral fin breeding tubercles in zebrafish
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Th,-e mechanistic insights into the application of retinoids and possible adjunct therapeutic treatment to androgenic alopecia
- Apoptotic clearance by stem cells: molecular mechanisms for recognition and phagocytosis of dead cells
- Dermatological care of gender‐diverse patients in Australia
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- Chronic Erythematous Plaques Around the Ears
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Olumiant® (Baricitinib)-A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata.
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Submission to the College of Physicians and Surgeons of Ontario Re: Medical Assistance in Dying
- The Legal Status and Liability of the OH Professional
- OR09-5 Importance of Islet Intracrinology for Glucose-Stimulated Insulin Secretion (GSIS) in the Male
- Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men
- Abstract 5561: 20(S)-Protopanaxadiol-aglycone downregulates full-length and ligand-independent splice variants of androgen receptor
- Medico Legal Memories